openPR Logo
Press release

Arthritis Foundation Expands Annual Juvenile Arthritis Conference to Two Locations

07-14-2016 04:14 PM CET | Health & Medicine

Press release from: Arthritis Foundation

/ PR Agency: Cookerly Public Relations
Arthritis Foundation Expands Annual Juvenile Arthritis

Kicking off during Juvenile Arthritis Awareness Month, the Arthritis Foundation is hosting two Juvenile Arthritis Conferences over the next five weeks. Almost 2,000 children and family members – a record attendance number – will gather in Phoenix, July 14–17, and Philadelphia, Aug. 11–14, to learn more about coping with their disease and meet other families who share their journey.

Arthritis afflicts nearly 300,000 children in the United States – and July is the month devoted to raising awareness for their cause. Each year, the Arthritis Foundation hosts the Juvenile Arthritis Conference for these children and families to join together and support one another while they work to overcome their everyday challenges. The conference provides attending children and their family members with the opportunity to make lasting friendships while participating in both educational sessions and fun activities throughout the event.

This year’s conference, themed “Stronger than Arthritis,” will feature a number of events for participants, including:

Opening night dinner themed State Night, allowing attendees to show their hometown spirit by wearing a state shirt or favorite sports team gear

A meet and greet with actress Grace Bannon, best known for her recurring role in the hit television series “The Middle,” who was diagnosed with JA at the age of 15

Programming tracks for children, young adults and parents, including breakout sessions, reflection time and parent networking opportunities

Presentations from rheumatologists, researchers, arthritis advocates and inspirational speakers

The presentation of the 2016 JA Awards of Excellence, recognizing outstanding leaders in the categories of youth, parent, health care professional and physician

The Arthritis Foundation offers life-changing programs, support and resources that are tailored to the unique needs and challenges of children and families with arthritis and rheumatic diseases. The conference is designed to provide a place where families are understood, can make connections and leave knowing that they have an entire community fighting for them.

“We are proud to host the 32nd JA Conference, bringing together children and their families who are affected with this disease together. The conference has positively impacted tens of thousands of lives since 1984,” said Ann Palmer, Arthritis Foundation president and CEO.

“Our hope is that those attending are fueled with even greater courage and passion to conquer JA and other childhood rheumatic diseases. By coming together, we are one step closer to a cure.”

The conference is made possible by the contribution of generous sponsors including Abbvie, Novartis, Amgen, Genentech and Medac Pharma. Additional information on juvenile arthritis and this year’s conference is available at

About the Arthritis Foundation:
The Arthritis Foundation is the Champion of Yes. Leading the fight for the arthritis community, the Foundation helps conquer everyday battles through life-changing information and resources, access to optimal care, advancements in science and community connections. The Arthritis Foundation’s goal is to chart a winning course, guiding families in developing personalized plans for living a full life – and making each day another stride toward a cure. The Foundation also publishes Arthritis Today, the award-winning magazine that reaches 4million readers.

Cookerly Public Relations
Monarch Tower
3424 Peachtree Rd NE
Suite 500
Atlanta, GA 30326

Contact: Chip Stewart
Phone: 404-816-2037

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Arthritis Foundation Expands Annual Juvenile Arthritis Conference to Two Locations here

News-ID: 349132 • Views: 1013

More Releases from Arthritis Foundation

Global ARTHRITIS Consumption 2017 Market Research Report
ARTHRITIS A market study based on the " ARTHRITIS Market " across the globe, recently added to the repository of Market Research, is titled ‘Global ARTHRITIS Market 2017’. The research report analyses the historical as well as present performance of the worldwide ARTHRITIS industry, and makes predictions on the future status of ARTHRITIS market on the basis of this analysis. Get Free Sample Copy of Report Here : The report studies the

More Releases for Juvenile

Juvenile Myelomonocytic Leukemia Therapeutics- Pipeline Analysis 2018
Juvenile myelomonocytic leukemia is a rare disease that occurs mostly in the children who are under four years of age. The abnormal growth of the monocytes results in the accumulation of monocytes in the bone marrow. Download the sample report @ This leads to improper functioning of the bone marrow. The actual cause of juvenile myelomonocytic leukemia is still unknown; however, mutation in the RAS gene is observed in patients
Juvenile Insurance Market
The Juvenile Insurance market report gives CAGR value, SWOT Analysis, Industry Chains, Mergers & Acquisitions, Sales, Revenue, Price, Gross Margin, Market Share, Import-Export, Production, Consumption, Application, Competitor analysis and Forecast. Get Exclusive Sample of Report on Juvenile Insurance market having 107 pages, profiling 16 Leading Market Players . The Juvenile Insurance market report covers major regions North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Malaysia,
Juvenile Idiopathic Arthritis Therapeutics Market
JIA is also known as juvenile idiopathic arthritis and is the most common inflammatory arthritis of childhood, musculoskeletal pain is a common symptom in childhood and is usually benign and self-resolving. JIA is affected to children who are under age 17. Recognizing rare but treatable causes, including inflammatory, malignant and infectious etiologies, remains a constant challenge. According to the American College of Rheumatology, Juvenile idiopathic arthritis affects one in 1000
Global Toys & Juvenile Products Market Size in 2022
– YEAR END BONANZA – Flat 20% discount on purchase of reports from 1st December to 31st December. * Terms & Conditions apply!! Contact No. : +16269994607 (US)/+91 7507349866 (IND) Email: Ask for 20% discount on this report The Global Toys & Juvenile Products Market report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Toys & Juvenile Products in these regions, from 2012 to 2022
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2017, provides an overview of the Juvenile Macular Degeneration (Stargardt Disease) (Ophthalmology) pipeline landscape. Juvenile macular degeneration is a series of inherited eye disorders
EU Standards for Juvenile Products
In 2015, there were a number of updates to the standards governing juvenile products. These included updates to standards governing modes of juvenile transport, as well as for child use and care articles. Here’s a summary: Transport • Rain covers (NF S54-043: 2015) • Soft baby carriers (EN 13209-2: 2015) General • Child use and care articles o Part 1 – Safety philosophy and safety assessment (CEN TR13387-1: 2015) o Part 2 – Chemical hazards (CEN TR13387-2: 2015) o Part 3 – Mechanical hazards